Page 241 - Clinical Small Animal Internal Medicine
P. 241

21  Supraventricular Arrhythmias  209

               Table 21.2  Drug dosages and indications
  VetBooks.ir   Drug name             Dosage                                           Indications



                Atropine              SC, IM, IV: 0.02–0.04 mg/kg (D, C)               Sinus bradycardia
                                                                                       Sick sinus syndrome,
                                                                                       First‐ and second‐degree AV block
                Glycopyrrolate        SC, IM, IV: 0.005–0.01 mg/kg (D, C)              Sinus bradycardia
                                                                                       Sick sinus syndrome,
                                                                                       First‐ and second‐degree AV block
                Terbutaline           Oral: 0.2 mg/kg q8–12h (D)                       Sinus bradycardia
                                      0.625 mg q8–12h (C)                              Sick sinus syndrome
                                      IV: 0.01 mg/kg IV (D, C)
                Isoproterenol         CRI: 0.04–0.09 μg/kg/min, to effect (D,C)        Second‐ and third‐degree AV block
                Aminophylline/        Oral: 10 mg/kg q12h (extended release) (D, C)    Sick sinus syndrome
                Theophylline          IV: 10 mg/kg (D)
                Digoxin               Oral: 0.005 mg/kg q12h (D)                       AF (rate control)
                Diltiazem             IV bolus: 0.1–0.4 mg/kg over 5 min (D, C)        SVT (rate control or conversion)
                                      CRI: 0.05–0.15 mg/kg/h (D, C)                    AF (rate control)
                                      Oral: 1–2 mg/kg q8h (D, C)
                                      3 mg/kg q12h (extended release) (D)
                                      15–30 mg q12–24h (extended release) (C)
                Atenolol              Oral: 0.2–1 mg/kg q12‐24h (D)                    SVT (rate control or conversion)
                                      6.25–12.5 mg q12–24h (C)                         AF (rate control)
                Esmolol               IV bolus: 0.2–0.5 mg/kg over 1 min, repeat q5min (D, C)  SVT conversion
                Procainamide          IV bolus: 5–15 mg/kg over 1 min (D)              SVT conversion
                                      1–2 mg/kg (C)
                                      CRI: 20–50 μg/kg/min (D)
                Lidocaine             IV bolus: 2 mg/kg over 30 s. Maximum 3 boluses (D)  SVT conversion
                                      0.25–0.5 mg/kg (C)                               Vagally mediated AF conversion
                Sotalol               Oral: 1–3 mg/kg q12h (D, C)                      SVT conversion
                                                                                       SR maintenance
               AF, atrial fibrillation; AV, atrioventricular; C, cat; CRI, constant rate infusion; D, dog; IM, intramuscular; IV, intravenous; SC, subcutaneous;
               SR, sinus rhythm; SVT, supraventricular tachycardia.





                 primary cardiac disease, myocarditis, or as a manifesta­  Signalment
               tion of a neuromuscular disorder. However, the etiology   Atrial standstill has been identified in various dog
               often remains unknown.                             breeds, with a possible higher prevalence in English
                 Hyperkalemia is described as a cause for transient
               atrial standstill. Other possibilities include quinidine or   springer spaniels. It usually affects young adults, but
                                                                  can be diagnosed as early as 4–6 months of age. Most
               digoxin  toxicity,  myocardial  infarction,  hypoxia,  and   cats diagnosed with atrial standstill have echocardio­
               hypothermia.                                       graphic  changes  consistent  with  hypertrophic
                 In the presence of persistent atrial standstill, the combi­
               nation of chronic bradycardia, lack of atrial contribution   cardiomyopathy.
               to ventricular filling and decreased atrial natriuretic pep­
               tide production results in low cardiac output, increased   History and Clinical Signs
               circulating blood volume, and ultimately heart failure.
                                                                  Most animals show signs of low cardiac output, includ­
                                                                  ing profound lethargy and syncope, in addition to
               Epidemiology
                                                                    evidence of left‐ or right‐sided congestive heart failure.
               It is a rare arrhythmia in dogs, and there are only a few   In rare cases of muscular dystrophies, progressive skele­
               documented cases in cats.                          tal muscle wasting may occur.
   236   237   238   239   240   241   242   243   244   245   246